Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab. J. Anal. Oncol. [Internet]. 2013 Dec. 28 [cited 2026 Apr. 29];2(4): 218-225. Available from: https://neoplasiaresearch.com/index.php/jao/article/view/89